New drug hope for short bowel patients: could crofelemer cut IV needs?
NCT ID NCT06326645
First seen Feb 14, 2026 · Last updated May 20, 2026 · Updated 9 times
Summary
This early-stage study tests a drug called crofelemer in 6 adults with short bowel syndrome who have an ileostomy and rely on IV nutrition. The goal is to see if the drug can reduce stoma output and the amount of IV support needed. Participants take crofelemer powder three times daily for 12 weeks, with a 4-week follow-up.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleveland Clinic Main Campus
RECRUITINGCleveland, Ohio, 44106, United States
Contact
Conditions
Explore the condition pages connected to this study.